MSC Therapy for Chronic Kidney Disease: What the 2025 Evidence Shows
A 2025 meta-analysis of 52 studies, real-world Taiwan data, and Mayo Clinic intraarterial delivery results — what nephrologists need to know about MSCs and CKD.
A 2025 meta-analysis of 52 studies, real-world Taiwan data, and Mayo Clinic intraarterial delivery results — what nephrologists need to know about MSCs and CKD.
A medical review of MSC-based and MSC-derived EV therapies for idiopathic pulmonary fibrosis, covering meta-analysis data, immune-cloaked cell engineering, nebulized exosome delivery, gut-lung axis mechanisms, and active clinical trials.
The 2026 evidence base for mesenchymal stem cell therapy in ischemic stroke includes a 26-study umbrella review and an 18-RCT network meta-analysis of 1,006 patients. MSCs were the only cell type to significantly reduce mortality. This medical review synthesizes the latest clinical data, mechanisms, active trials, and translational barriers.
В нашей клинике в Бангкоке изучают, как терапия с использованием мезенхимальных стволовых клеток помогает пациентам с ХОБЛ легче дышать — уменьшая воспаление, активируя стволовые клетки легких и улучшая качество жизни.
Стоимость терапии стволовыми клетками варьируется от $2000 до $100000 в зависимости от места проведения. Вот что на самом деле влияет на стоимость, что входит в пакет услуг и как Таиланд соотносится с США, Австралией и Европой в 2026 году.
A 2026 meta-analysis of 15 RCTs shows MSCs cut acute GvHD incidence by 53% and chronic GvHD by 50%. A biomarker-guided trial identifies which transplant patients benefit most — and a cell-free exosome approach may be next.
Learn how MSC therapy is offering real hope for liver cirrhosis patients — with data from the latest 2026 clinical trials and real patient outcomes at our Bangkok clinic.
Diabetic wounds that refuse to heal affect hundreds of thousands of Thais. Discover how exosome therapy and MSC treatment are giving patients a real path to recovery.